Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma

NCT01025206

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Maryland, Greenebaum Cancer Center Baltimore, Maryland, United States

University of Utah Health Sciences Center, Department of Medicine, Division of Hematology, Utah Blood and Marrow Transplant and Myeloma Program Salt Lake City, Utah, United States

AZ Sint-Jan Bruges, Belgium

Ghent University Hospital Ghent, Belgium

View Trial Details

Completed

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

NCT00412243

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Burkitt's Lymphoma, +21 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT00823719

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

A Retreatment Study With Bortezomib for Multiple Myeloma

NCT01030302

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma

NCT00008242

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma

NCT00002738

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +26 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma

NCT01806337

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

NCT00014469

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +39 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT

NCT01478191

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations: Istituto Oncologico del Mediterraneo Catania, Italy

Policlinico Maggiore Milan, Italy

Ospedale San Gennaro Naples, Italy

Azienda Ospedaliera V. Cervello Palermo, Italy

View all 40 locations

View Trial Details

Completed

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

NCT00661544

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions